Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| CG Oncology, Inc.COMM(CGON) | 3,570,206 | 3,670,206 | +100,000 | $156.73M | $115.87M | 12.08% | -$40.86M |
| Dyne Therapeutics, Inc.COMM(DYN) | 2,650,150 | 2,650,150 | 0 | $75.24M | $93.52M | 9.75% | +$18.29M |
| ABIVAX Société AnonymeADRS(ABVX) | 1,100,000 | 6,056,596 | +4,956,596 | $15.73M | $80.07M | 8.34% | +$64.34M |
| Silence Therapeutics plcADRS(SLN) | 3,295,350 | 3,295,350 | 0 | $71.18M | $62.61M | 6.53% | -$8.57M |
| Cogent Biosciences, Inc.COMM(COGT) | 6,214,375 | 6,964,375 | +750,000 | $41.76M | $58.71M | 6.12% | +$16.95M |
| Savara Inc.COMM(SVRA) | 10,000,000 | 12,362,205 | +2,362,205 | $49.80M | $49.82M | 5.19% | +$19.7K |
| Madrigal Pharmaceuticals, Inc.COMM(MDGL) | 149,283 | 149,283 | 0 | $39.86M | $41.82M | 4.36% | +$1.96M |
| Edgewise Therapeutics, Inc.COMM(EWTX) | 2,272,728 | 2,272,728 | 0 | $41.45M | $40.93M | 4.27% | -$522.7K |
| Keros Therapeutics, Inc.COMM(KROS) | 879,344 | 879,344 | 0 | $58.21M | $40.19M | 4.19% | -$18.03M |
| Mineralys Therapeutics, Inc.COMM(MLYS) | 3,185,185 | 3,185,185 | 0 | $41.12M | $37.27M | 3.88% | -$3.85M |
| Ocular Therapeutix, Inc.COMM(OCUL) | 5,319,148 | 5,319,148 | 0 | $48.40M | $36.38M | 3.79% | -$12.02M |
| Tyra Biosciences, Inc.COMM(TYRA) | 1,989,103 | 1,989,103 | 0 | $32.62M | $31.81M | 3.31% | -$815.5K |
| Kura Oncology, Inc.COMM(KURA) | 1,423,642 | 1,423,642 | 0 | $30.37M | $29.31M | 3.06% | -$1.05M |
| Structure Therapeutics IncADRS | 1,598,421 | 694,547 | -903,874 | $68.51M | $27.27M | 2.84% | -$41.23M |
| Centessa Pharmaceuticals PlcCOMM | 2,040,816 | 2,890,816 | +850,000 | $23.06M | $26.10M | 2.72% | +$3.04M |
| Astria Therapeutics, Inc.COMM | 5,278,928 | 2,761,861 | -2,517,067 | $74.30M | $25.13M | 2.62% | -$49.17M |
| COMPASS Pathways plcADRS(CMPS) | 3,858,000 | 3,858,000 | 0 | $32.10M | $23.30M | 2.43% | -$8.80M |
| Soleno Therapeutivs, Inc.COMM | 550,000 | 550,000 | 0 | $23.54M | $22.44M | 2.34% | -$1.10M |
| Disc Medicine, Inc.COMM(IRON) | 0 | 486,957 | +486,957 | $0 | $21.95M | 2.29% | +$21.95M |
| Tourmaline Bio IncCOMM | 1,477,593 | 1,477,593 | 0 | $33.84M | $19.00M | 1.98% | -$14.84M |
| Tarsus Pharmaceuticals, Inc.COMM(TARS) | 793,829 | 556,317 | -237,512 | $28.86M | $15.12M | 1.58% | -$13.73M |
| Adverum Biotechnologies, Inc.COMM | 2,008,340 | 2,008,340 | 0 | $28.40M | $13.78M | 1.44% | -$14.62M |
| Vistagen Therapeutics, Inc.COMM(VTGN) | 2,676,580 | 2,676,580 | 0 | $14.13M | $9.31M | 0.97% | -$4.82M |
| Entrada Therapeutics, Inc.COMM(TRDA) | 584,955 | 584,955 | 0 | $8.29M | $8.34M | 0.87% | +$46.8K |
| EyePoint, Inc.COMM(EYPT) | 0 | 922,335 | +922,335 | $0 | $8.02M | 0.84% | +$8.02M |
| C4 Therapeutics, Inc.COMM(CCCC) | 1,276,574 | 1,276,574 | 0 | $10.43M | $5.90M | 0.61% | -$4.53M |
| Nektar TherapeuticsCOMM(NKTR) | 4,000,000 | 4,000,000 | 0 | $3.74M | $4.96M | 0.52% | +$1.22M |
| Aerovate Therapeutics IncCOMM | 2,201,274 | 2,240,809 | +39,535 | $65.09M | $3.72M | 0.39% | -$61.37M |
| AN2 Therapeutics, Inc.COMM | 1,555,118 | 1,555,118 | 0 | $5.05M | $3.34M | 0.35% | -$1.71M |
| Kodiak Sciences Inc.COMM(KOD) | 899,999 | 899,999 | 0 | $4.73M | $2.11M | 0.22% | -$2.62M |
| Ventyx Biosciences, IncCOMM | 815,724 | 316,195 | -499,529 | $4.49M | $730.4K | 0.08% | -$3.76M |
| Cabaletta Bio, Inc.COMM(CABA) | 86,795 | 86,795 | 0 | $1.48M | $649.2K | 0.07% | -$831.5K |
| Geron CorporationCOMM(GERN) | 17,391,639 | 0 | -17,391,639 | $57.39M | $0 | — | -$57.39M |
| Inhibrx,incCOMM | 1,750,387 | 0 | -1,750,387 | $61.19M | $0 | — | -$61.19M |
| Kalvista Pharmaceuticals, IncCOMM | 1,163,356 | 0 | -1,163,356 | $13.80M | $0 | — | -$13.80M |